Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 310
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis Appendix B Workshop Agendas NEW APPROACHES TO BREAST CANCER DETECTION (WORKSHOP #1) National Academy of Sciences Building Washington, DC January 7, 2003 9:00 Welcome and Introduction Ed Penhoet, Committee Chair 9:10 Overview of Current Options in Breast Cancer Detection Laura Esserman, University of California San Francisco 9:40 Comparisons of Multiple Modalities: US, PET, MRI, Optical Mitchell Schnall, University of Pennsylvania 10:10 Technical Advances in Mammography: Digital Mammography and DEI Etta Pisano, University of North Carolina 10:40 Comparison of Four Breast Imaging Techniques Keith Paulsen, Dartmouth 11:10 Computer Assisted Diagnosis Maryellen Giger, University of Chicago 11:40 DISCUSSION
OCR for page 311
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis 12:00 LUNCH 12:45 Introduction to Tumor Markers Jeff Marks, Duke University Medical Center 12:50 The Search for Breast Cancer Biomarkers Sara Sukumar, Johns Hopkins Oncology Center 1:20 Deciphering the Molecular Signatures of Breast Cancer Lance Liotta, Laboratory of Pathology, National Cancer Institute 1:50 Molecular Imaging David Piwnica-Worms, Washington University 2:20 DISCUSSION 2:30 BREAK 2:45 Making Sense of the Mountains of Data: Bioinformatics and Breast Cancer Detection Michael Vannier, National Cancer Institute/University of Iowa 3:15 SmartProbe: Spin-off Technology from NASA Richard Hular, BioLuminate, Inc. 3:30 TransScan: Post-Script on a 1999 “Medical Breakthrough” John Neugebauer, TransScan Medical, Inc. 3:45 Optical Scanning, Almost Approved Phillip C. Thomas, DOBI, Inc. 4:00 DISCUSSION 4:15 WRAP-UP 4:45 ADJOURN
OCR for page 312
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #2) Keck Center of the National Academies Washington, DC February 18, 2003 9:00 Welcome and Introduction Ed Penhoet, Committee Chair 9:10 Marketing Strategies: How Companies Work to Encourage Adoption of New Medical Technologies Laura Shapiro, Siemens Medical Solutions 10:00 The Role of Innovative Not-for-Profits in Medical Innovation: Lessons from CaP CURE Howard Soule, CaP CURE 10:50 The Role of Breast Cancer Philanthropies in Developing New Approaches to Breast Cancer Detection Susan Braun, Susan G. Komen Foundation 11:40 DISCUSSION 3:00 ADJOURN FROM DEVELOPMENT TO ADOPTION OF NEW APPROACHES TO BREAST CANCER DETECTION AND DIAGNOSIS (WORKSHOP #3) National Academy of Sciences Building Washington, DC March 25, 2003 9:30 Welcome and Introduction Ed Penhoet, Committee Chair 9:35 NCI Programs to Support Development of New Approaches to Breast Cancer Detection Ed Staab, Branch Chief, Diagnostic Imaging, NCI
OCR for page 313
Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis 10:15 Regulatory Challenges for In Vitro Diagnostics Joseph Hackett, Special Projects Officer, Office of In Vitro Diagnostics, FDA 10:55 Challenges in Assessing the Safety and Efficacy of Cancer Detection Devices David Feigal, Director, Center for Devices and Radiological Health, FDA 11:35 DISCUSSION 12:30 LUNCH 1:15 CMS Perspective on Adoption of New Breast Cancer Detection Technologies Sean Tunis, Acting Chief Medical Officer, CMS 1:55 Private Health Payers’ Perspective on Adoption of New Breast Cancer Detection Technologies Alan Rosenberg, Vice President of Medical and Credentialing Policy, WellPoint Health Networks 2:35 DISCUSSION 2:50 BREAK 3:10 Better Information and Decision Tools: The Needs of the Consumer Mary Ropka, University of Virginia Medical School 3:50 Decision Support in Breast Cancer Detection Options: Health Systems Perspective Nananda Col, Brigham & Women’s Hospital 4:30 DISCUSSION 4:45 ADJOURN
Representative terms from entire chapter: